AQUINOX PHARMACEUTICALS INC Chart calendar Aquinox Pharmaceuticals Inc
1871051bde6788.bQWskrlg0D5vUIf3Au2Iht75Gj3QZJp49MY4J48VmUA.XkrDwI0itRMnAODFN66x6LmqeW-nHMpIw5lWcLpk-y0lct7F2hagbjoGsw~78f6a4f50d14eda7ea42736e1ea9c4ec
Upcoming events on Aquinox Pharmaceuticals Inc
Past events on Aquinox Pharmaceuticals Inc
| 2024-03-20 09:30 am | Stifel CNS Day |
| 2024-03-18 04:14 pm | Q4 2023 Earnings Release |
| 2024-03-10 | Leerink Partners Global Biopharma Conference |
| 2024-03-05 10:30 am | TD Cowen Health Care Conference |
| 2023-07-18 08:30 am | Neoleukin Therapeutics, Inc. and Neurogene Inc. Merger Call |
| 2023-06-08 04:30 pm | Annual General Meeting |
| 2023-05-09 03:42 pm | Q1 2023 Earnings Release |
| 2022-12-12 12:45 pm | American Society of Hematology Meeting - Publication Number: 684 |
| 2022-11-14 04:03 pm | Q3 2022 Earnings Release |
| 2022-08-10 01:00 pm | Canaccord Growth Conference |
| 2022-08-09 04:30 pm | Interim 2022 Earnings Call |
| 2022-08-09 04:02 pm | Interim 2022 Earnings Release |
| 2022-05-25 12:30 pm | H.C. Wainwright Global Life Sciences Investment Conference |
| 2022-05-12 04:30 pm | Annual General Meeting |
| 2022-05-11 04:20 pm | Bank of America Healthcare Conference |
| 2022-05-09 04:05 pm | Q1 2022 Earnings Release |
| 2022-04-14 12:00 pm | Canaccord Horizons in Oncology Virtual Conference |
| 2022-04-13 10:00 am | American Association of Cancer Research Meeting - Abstract No 4227 |
| 2022-04-13 10:00 am | American Association of Cancer Research Meeting - Abstract No CT250 |
| 2022-04-11 02:30 pm | American Association of Cancer Research Meeting - Abstract No 2067 |
Annual results
| Fiscal Period | December | 2022 | 2023 | 2024 |
|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -55,6 -56,3 1.33% | -65,2 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -36,3 -53,6 32.24% | -59,2 |
|
Net income Million USD | Released Forecast Spread | -55,2 | -36,3 -53,9 32.58% | -66,9 |
|
EPS USD | Released Forecast Spread | -10,6 | -7,80 -5,58 -39.84% | -3,62 |
| Announcement Date | 08/11/23 | 18/03/24 | - |
Quarterly results
| Fiscal Period | December | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -14,7 -15,5 4.64% | -15,3 | -15,9 | -16,6 | -17,4 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 2,38 -14,9 116% | -13,8 | -14,4 | -15,1 | -15,9 |
|
Net income Million USD | Released Forecast Spread | 2,38 -15,1 115.75% | -17,1 | -15,7 | -16,7 | -17,7 |
|
EPS USD | Released Forecast Spread | -1,17 | -1,00 | -0,91 | -0,95 | -0,86 |
| Announcement Date | 18/03/24 | - | - | - | - |
